FDA Inspection 552390 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3022159

The FDA completed an inspection of Biomat USA, Inc. on December 9, 2008 in Boise, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 9, 2008
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boise, ID (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs